Ensifentrine
Verona Pharma has recently filed a New Drug Application to FDA for the use of ensifentrine as a maintenance treatment for chronic obstructive pulmonary disease
SG Tylor
Source – Verona Pharma On June 27, 2023, Verona Pharma announced the submission of a New Drug Application (NDA) to ...
